Anteris Ends v2vmedtech Development Agreement, Limits Exposure
at www.tipranks.com (Wed, 29-Apr 6:45 PM)
Anteris Bolsters U.S. Momentum as CMS Reimbursement Unlocks PARADIGM Trial Site Activations
Market Chameleon (Tue, 28-Apr 8:00 AM)
